109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
#5402Oligonucleotides to treat eye disease
#5403METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISEASE
#5404Method and composition for targeted delivery of therapeutic agents
#5405Control of hemipteran pests using RNA molecules
#5406COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#5407NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS
#5408Methods for treatment of polycystic kidney disease
#5409Gene therapies for lysosomal disorders
#5410Reducing intron retention
#5411COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF FACTOR V
#5412Double-stranded RNA molecule targeting CKIP-1 and use thereof
#5413Agents useful in treating facioscapulohumeral muscular dystrophy
#5414Gene therapies for lysosomal disorders
#5415Use of Circ-CDH1 inhibitors
#5416Nucleic acid oligomers and uses therefor
#5417HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#5418METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS
#5419GENOME EDITING METHOD
#5420ANTISENSE OLIGONUCLEOTIDE DIRECTED REMOVAL OF PROTEOLYTIC CLEAVAGE SITES, THE HCHWA-D MUTATION, AND TRINUCLEOTIDE REPEAT EXPANSIONS
#5421Methods and compositions for modulating splicing
#5422COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#5423Functional nucleic acid molecule and use thereof
#5424Single-stranded oligonucleotide
#5425METHODS OF MODULATING FAM46A
#5426Compositions and methods of modulating macrophage activity
#5427Pharmaceutical carriers containing miRNAs for use in the treatment of fibrotic diseases caused by hyperglycemia
#5428Composition for prevention or treatment of spinocerebellar ataxia type 36
#5429NUCLEOCYTOPLASMIC REGULATOR OF AUTOPHAGY-ASSOCIATED TRANSCRIPTION FACTORS
#5430Hybridosomes, compositions comprising the same, processes for their production and uses thereof
#5431METHOD FOR SUPPRESSING BRAIN METASTASIS
#5432DELIVERY OF A GENE-EDITING SYSTEM WITH A SINGLE RETROVIRAL PARTICLE AND METHODS OF GENERATION AND USE
#5433MATERIALS AND METHODS FOR TREATMENT OF SPINOCEREBELLAR ATAXIA TYPE 2 (SCA2) AND OTHER SPINOCEREBELLAR ATAXIA TYPE 2 PROTEIN (ATXN2) GENE RELATED CONDITIONS OR DISORDERS
#5434Variant RNAi
#5435Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke
#5436Antisense Compounds and Uses Thereof
#5437ANTISENSE OLIGONUCLEOTIDES FOR MODULATING RELA EXPRESSION
#5438SERPINC1 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5439Systems and methods for treating alpha 1-antitrypsin (A1AT) deficiency
#5440CHEMICALLY MODIFIED OLIGONUCLEOTIDES
#5441Sequential gene editing in primary immune cells
#5442Engineered nucleic acid-targeting nucleic acids
#5443ALLELE SELECTIVE INHIBITION OF MUTANT C9ORF72 FOCI EXPRESSION BY DUPLEX RNAS TARGETING THE EXPANDED HEXANUCLEOTIDE REPEAT
#5444Long noncoding RNAs in pulmonary airway inflammation
#5445STABILIZED SARNA COMPOSITIONS AND METHODS OF USE
#5446Compositions and methods for messenger RNA inhibitors
#5447METHODS FOR TREATING OR PREVENTING CONTACT-ACTIVATION PATHWAY-ASSOCIATED DISEASES USING iRNA COMPOSITIONS TARGETING FACTOR XII (HAGEMAN FACTOR) (F12)
#5448Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use
#5449Using nucleosome interacting protein domains to enhance targeted genome modification
#5450Means and methods for producing phosphate containing capsular polysaccharides
#5451Platelets as delivery agents
#5452METHODS FOR MODULATING THE INTERACTION BETWEEN EWS-FLI1 AND BAF COMPLEXES
#5453Hippo pathway deficiency reverses systolic heart failure post-infarction
#5454LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5455Methods of treatment of cancer with reduced UBB expression
#5456INSTANT THICKENED DRY FOOD COMPOSITIONS
#5457ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#5458Adeno-associated virus (AAV) producer cell line and related methods
#5459RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3
#5460Viral vector production
#5461Artificial genome manipulation for gene expression regulation
#5462Inducible expression of genes in algae
#5463Allele-specific therapy for Huntington disease haplotypes
#5464tRNA derived small RNAs (tsRNAs) involved in cell viability
#5465Expression control using a regulatable intron
#5466siRNA Therapy for Transthyretin (TTR) Related Ocular Amyloidosis
#5467Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
#5468Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#5469Compounds and methods for reducing Tau expression
#5470Polycomb-Associated Non-Coding RNAs
#5471Functionally-interdependent shape switching nucleic acid nanoparticles
#5472Targeted RNA editing
#5473Method for the construction of specific promoters
#5474Compositions and methods for non-antibiotic treating of bacterial infections by blocking or disrupting bacterial genes involved in virulence or viability
#5475Variant Cas9 polypeptides comprising internal insertions
#5476Cationic lipids for therapeutic agent delivery formulations
#5477EXTRACELLULAR VESICLES FOR AGENT DELIVERY
#5478REFILLABLE DRUG DELIVERY DEVICES AND METHODS OF USE THEREOF
#5479Antagonists of Products of the HS.459642 Unigene Cluster for the Inhibition of Proliferation, Development or Differentiation of Stem Cells Including Cancer Stem Cells
#5480Methods And Compositions For Controlling Cardiac Fibrosis And Remodeling
#5481DRUG CARRIER AND DRUG DELIVERY SYSTEM THEREOF
#5482Compositions and methods to control insect pests
#5483KIT FOR EVALUATING GENE MUTATION RELATED TO MYELOPROLIFERATIVE TUMOR
#5484THREE MOLECULAR MARKERS, KITS AND APPLICATIONS FOR GLAUCOMA DIAGNOSIS
#5485Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5486METHODS FOR REDUCING DNA-INDUCED CYTOTOXICITY AND ENHANCING GENE EDITING IN PRIMARY CELLS
#5487GENETIC TARGETING IN NON-CONVENTIONAL YEAST USING AN RNA-GUIDED ENDONUCLEASE
#5488COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION
#5489Brush polymer-assisted compaction of oligonucleotides
#5490Peptide, complex of peptide and siRNA, and methods of use thereof
#5491Organic compositions to treat EPAS1-related diseases
#5492EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY
#5493Oligonucleotide compositions and methods of use thereof
#5494Nucleic acid suppressing expression of APCS
#5495Methods and systems for analyzing guide RNA molecules
#5496Nucleic acid molecules and their use in therapy
#5497MICRO-RNA FAMILY THAT MODULATES FIBROSIS AND USES THEREOF
#5498Agents and methods to elicit anti-tumor immune response
#5499Targeting gene amplification in cancer using triplex formation as a therapeutic strategy
#5500COMPOUNDS AND METHODS FOR INHIBITING CDK5 ALLEVIATE CARDIAC PHENOTYPES IN TIMOTHY SYNDROME AND RELATED CONDITIONS
#5501Anellovirus compositions and methods of use
#5502Compositions and methods for the treatment of fibrotic diseases
#5503Inhibition of expansion and function of pathogenic age-associated B cells and use for the prevention and treatment of autoimmune disease
#5504METHODS FOR IDENTIFYING THERAPEUTIC AGENTS WHICH INTERACT WITH STK24
#5505MICRO-RNAS THAT MODULATE LYMPHANGIOGENESIS AND INFLAMMATORY PATHWAYS IN LYMPHATIC VESSEL CELLS
#5506Primary cell gene editing
#5507RNAI APPROACH FOR CROP PEST PROTECTION
#5508ENHANCEMENT OF PLANT YIELD VIGOR AND STRESS TOLERANCE
#5509Compositions of self-reporting transposon (SRT) constructs and methods for mapping transposon insertions
#5510Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
#5511Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#5512Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
#5513Antisense oligonucleotides for the treatment of eye disease
#5514Anti-inflammatory treatment via inhibition of endothelial cell kinesin light chain 1, variant 1 (KLC1C)
#5515COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#5516COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
#5517Method of treating cancer by antisense oligonucleotides targeting PRDM15
#5518Gene-regulating compositions and methods for improved immunotherapy
#5519NANOSTRUCTURES FOR PENETRATING DEEP INTO CANCER TISSUES
#5520Collagen-mimetic peptide mediated delivery of nucleic acid carriers for efficient delivery from collagen
#5521Modulators of FOXP3 expression
#5522Systems and methods for the control of acute hepatopancreatic necrosis disease
#5523Colorectal cancer detection kit or device, and detection method
#5524CRISPR-CAS system for a yeast host cell
#5525Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
#5526Methods for genetic control of insect infestations in plants and compositions thereof
#5527METHODS OF MODULATING PROTEIN EXPRESSION FROM THE MENA-RIBONUCLEOPROTEIN COMPLEX IN CELLS
#5528ENA ANTISENSE OLIGONUCLEOTIDE FOR INHIBITION OF alpha-SYNUCLEIN EXPRESSION
#5529Compositions and methods for detecting and treating insulin resistance
#5530CasZ compositions and methods of use
#5531Lipids for use in lipid nanoparticle formulations
#5532HSV VECTOR WITH REDUCED NEUROTOXICITY
#5533Modulation of the notch signaling pathway for treatment of respiratory disorders
#5534Methods for treating hepatitis B infection
#5535Cancer Treatment Based on Delivery of Oligoes via Gap Junctions from Human Mesenchymal Stem Cells (hMSC)
#5536COTL1 protein involved in maintaining homeostasis of hematopoietic stem cell, and use thereof
#5537Methods and compositions for preparing tagatose from fructose
#5538CRISPR-CAS system for a lipolytic yeast host cell
#5539Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
#5540Primary cell gene editing
#5541Compositions for the treatment of disease
#5542TISSUE SELECTIVE TRANSGENE EXPRESSION
#5543Compositions and methods for controlling
#5544RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#5545Therapeutic splice-switching oligonucleotides
#5546Antisense oligonucleotide controlling expression amount of TDP-43 and use thereof
#5547METHODS OF IDENTIFYING MIRNAS AND APPLICATIONS THEREOF
#5548INHIBITION OF VASCULAR ENDOTHELIAL CELL-MEDIATED PHAGOCYTIC PROCESSES FOR TREATMENT OF DEMYELINATING CONDITIONS
#5549COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER
#5550Modified Oligonucleotides for Treatment of Polycystic Kidney Disease
#5551Mammalian cells for producing a secreted protein
#5552LncRNAs for therapy and diagnosis of cardiac hypertrophy
#5553PUM 1 protein as target for virus inhibition
#5554Method for treating neurodegenerative diseases
#5555Presymptomatic micro RNA targets for treatment of neurodegeneration pathology
#5556METHODS OF PRODUCING HUMAN CANCER CELL MODELS AND METHODS OF USE
#5557PLANT GENOME MODIFICATION USING GUIDE RNA/CAS ENDONUCLEASE SYSTEMS AND METHODS OF USE
#5558COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS
#5559EXOSOME LOADED THERAPEUTICS FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS, DIABETES MELLITUS TYPE 1 AND TYPE 2, ATHEROSCLEROTIC CARDIOVASCULAR DISEASE, AND ALPHA 1 ANTITRYPSIN DEFICIENCY
#5560RNA interference delivery formulation and methods for malignant tumors
#5561Use of therapeutic agents
#5562SMN2 element 1 antisense compositions and methods and uses thereof
#5563Modulating RNA Interactions with Polycomb Repressive Complex 1 (PRC1)
#5564Antisense therapies for treating cancer
#5565METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION
#5566INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY
#5567DEVICE AND METHOD FOR PROMOTING RAPID STRUT COVERAGE AND VASCULAR ENDOTHELIAL COVERAGE
#5568Therapeutic Membrane Vesicles
#5569Fungal immunogens and related materials and methods
#5570Compositions and methods of treating Huntington's disease
#5571Hornerin: a novel non-VEGF mediated angiogenic protein expressed in both human and mouse angiogenic endothelial cells and human pancreatic cancer cells
#5572METHODS AND COMPOSITIONS FOR GENOME EDITING
#5573Use of potassium channel inhibitor for treating depression
#5574Modulatory polynucleotides
#5575Control of insect infestation
#5576RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders
#5577MODULATING BIOMARKERS TO INCREASE TUMOR IMMUNITY AND IMPROVE THE EFFICACY OF CANCER IMMUNOTHERAPY
#5578Gene Therapy Drug for Granular Corneal Degeneration
#5579Antisense nucleic acids
#5580System and method for genome editing
#5581Method to reduce pulmonary arterial hypertension by administering inhibitors of nicotinamide phosphoribotransferase
#5582Antibodies and processes for preparing the same
#5583Oncolytic viral vectors and uses thereof
#5584COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS
#5585Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
#5586Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
#5587Nucleoporins as drug targets for anti-proliferative therapeutics
#5588Oligonucleotide analogues targeting human LMNA
#5589COMPOSITIONS AND METHODS FOR DETECTION, RISK ASSESSMENT AND TREATMENT OF DIABETES, OBESITY, AND INFLAMMATION
#5590Methods and compositions for the treatment of retinopathy and other ocular diseases
#5591Methods and compositions for the treatment of retinopathy and other ocular diseases
#5592METHODS AND COMPOSITIONS FOR MODULATING INNATE LYMPHOID CELL PATHOGENIC EFFECTORS
#5593Methods, compositions, and devices involving pseudoknot formation
#5594Viral delivery of RNA utilizing self-cleaving ribozymes and CRISPR-based applications thereof
#5595DOWN-REGULATING GENE EXPRESSION IN INSECT PLANTS
#5596Whole seed specific promoter
#5597Fidgetin-like 2 as a target to enhance wound healing
#5598Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#5599Identification of a JAK2 mutation in polycythemia vera
#5600Therapeutic agent for a lung disease and/or method for screening for the same
#5601Long non-coding RNA in cancer
#5602IncRNAs GADLOR 1 and 2 for use in treating and preventing cardiac remodelling
#5603COMPOUNDS THAT TARGET MYC microRNA RESPONSIVE ELEMENTS FOR THE TREATMENT OF MYC-ASSOCIATED CANCER
#5604Methods and means for treating DNA repeat instability associated genetic disorders
#5605METHOD OF SYNTHESIS OF AN IONIZABLE CATIONIC LIPID
#5606Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#5607Lipid compositions
#5608Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
#5609Myostatin iRNA compositions and methods of use thereof
#5610Enzymatic replacement therapy and antisense therapy for Pompe disease
#5611INCORPORATION OF UNNATURAL NUCLEOTIDES AND METHODS THEREOF
#5612Method for identifying DNA base editing by means of cytosine deaminase
#5613Factor XII (hageman factor) (F12), kallikrein B, plasma (fletcher factor) 1 (KLKB1), and kininogen 1 (KNG1) iRNA compositions and methods of use thereof
#5614Micropeptides and use of same for modulating gene expression
#5615Lipid nanoparticle formulation
#5616ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#5617Recombinant vector comprising ERT2 fused to CAS9
#5618Molecular system for cancer biology
#5619Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
#5620ANTI-REFLECTIVE ARTICLES WITH NANOSILICA-BASED COATINGS
#5621ANTISENSE NUCLEIC ACID FOR TREATING AMYOTROPHY
#5622Treatment strategies against anthrax by interfering with critical host factors
#5623GENE THERAPY TARGETING THE NEONATAL FORM OF NAV1.5 FOR TREATING CANCER
#5624Modified oligonucleotides targeting SNPs
#5625RNA COMPOSITIONS FOR GENOME EDITING
#5626NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#5627Methods for reducing post-operative cognitive dysfunction (POCD)
#5628ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSIDS AND METHODS OF USE THEREOF
#5629Methods and compositions for treating skeletal muscular dystrophy
#5630Double-stranded nucleic acid molecule, DNA, vector, cancer cell growth inhibitor, cancer cell migration inhibitor, and drug
#5631PANCREATIC CANCER TARGETS AND USES THEREOF
#5632Modulation of angiopoietin-like 3 expression
#5633HETERO DOUBLE-STRANDED antimiR
#5634Functionally-modified oligonucleotides and subunits thereof
#5635Systems, methods and compositions for sequence manipulation with optimized functional CRISPR-Cas systems
#5636Antisense nucleic acids
#5637PH-sensitive lipid nanoparticles for encapsulation of anticancer drugs and microRNA and use thereof
#5638P-ethoxy nucleic acids for liposomal formulation
#5639LACTATE DEHYDROGENASE A (LDHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5640NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#5641In vivo delivery of oligonucleotides
#5642Methods of reducing expression of x-inactivation escapee genes and autosomal genes
#5643Variant RNAi
#5644Splicing-dependent transcriptional gene silencing or activation
#5645Vectors and compositions for treating hemoglobinopathies
#5646Antisense nucleic acids
#5647Methods for the Delivery of Therapeutic Agents to Donor Organs
#5648Functional Nucleic Acid Protective Vector Based On DNA Hydrogel, Preparation Method and Application Thereof
#5649Engineered shell proteins for microcompartment shell electron transfer and catalysis
#5650EXOSOME LOADED THERAPEUTICS FOR TREATING SICKLE CELL DISEASE
#5651Beta-TUBULIN, Beta-TUBULIN GENE AND APPLICATION OF GENE SEGMENT THEREOF
#5652Compositions and methods for the treatment of hemoglobinopathies
#5653POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF
#5654Methods for controlling seizures by manipulating the levels of microRNA-211 (miR-211) in the brain
#5655DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS
#5656Compositions and methods for treating cancer with anti-ROR1 immunotherapy
#5657Compositions And Methods For Treating Cancer
#5658VIRAL EXPRESSION CONSTRUCT COMPRISING A FIBROBLAST GROWTH FACTOR 21 (FGF21) CODING SEQUENCE
#5659Antisense nucleic acids
#5660COMPOSITIONS AND METHODS FOR PRODUCING EXOSOME LOADED THERAPEUTICS FOR TREATING CARDIOVASCULAR DISEASE
#5661TRANSCRIPTION SYSTEM
#5662Methods for Producing Enteroendocrine Cells That Make and Secrete Insulin
#5663Methods for multiplexing recombinase polymerase amplification
#5664Methods and compositions for managing vascular conditions
#5665BCL11A guide delivery
#5666MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPODYSTROPHY POPULATIONS
#5667Products and compositions
#5668MATERIALS AND METHODS FOR TREATMENT OF MEROSIN-DEFICIENT COGENITAL MUSCULAR DYSTROPHY (MDCMD) AND OTHER LAMININ, ALPHA 2 (LAMA2) GENE RELATED CONDITIONS OR DISORDERS
#5669POLYNUCLEOTIDE AGENTS TARGETING COMPLEMENT COMPONENT C5 AND METHODS OF USE THEREOF
#5670FORMULATION COMPRISING EXTRACELLULAR VESICLES, METHOD FOR PRODUCING THE SAME, AND USES THEREOF
#5671ERBB3 Activators in Hearing Restoration
#5672Methods and compositions for the treatment of retinopathy and other ocular diseases
#5673Stable transformation of a population and a method of biocontainment using haploinsufficiency and underdominance principles
#5674Biomarkers and methods for diagnosis of early stage pancreatic ductal adenocarcinoma
#5675SYSTEMS
#5676AAV treatment of Huntington's disease
#5677O-methyl rich fully stabilized oligonucleotides
#5678Inhibition of poly(A) binding protein and the treatment of pain
#5679Compositions for modulating Ataxin 2 expression
#5680METHODS AND COMPOSITIONS FOR MODIFYING A SINGLE STRANDED TARGET NUCLEIC ACID
#5681TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER
#5682Vista modulators for diagnosis and treatment of cancer
#5683RNA VACCINE AND IMMUNE CHECKPOINT INHIBITORS FOR COMBINED ANTICANCER THERAPY
#5684TARGETING NR3B1 FOR TREATMENT OF NASH
#5685Method for prediction of susceptibility to sorafenib treatment by using SULF2 gene, and composition for treatment of cancer comprising SULF2 inhibitor
#5686CO-DELIVERY OF NUCLEIC ACIDS FOR SIMULTANEOUS SUPPRESSION AND EXPRESSION OF TARGET GENES
#5687NANOSCALE CARRIERS FOR THE DELIVERY OR CO-DELIVERY OF CHEMOTHERAPEUTICS, NUCLEIC ACIDS AND PHOTOSENSITIZERS
#5688ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA
#5689PROSTATIC CANCER MARKER, PLXNA1, AND APPLICATION THEREOF
#5690METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE
#5691Method for selective translation of desired proteins in the presence of a specified nucleic acid ligand
#5692Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#5693Crispr enzymes and systems
#5694CRISPR/CAS9-BASED COMPOSITIONS AND METHODS FOR TREATING RETINAL DEGENERATIONS
#5695RNAi strategies for control of whitefly
#5696SIMULTANEOUS GENE EDITING AND HAPLOID INDUCTION
#5697CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#5698APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#5699Twist signaling inhibitor compositions and methods of using the same
#5700Cationic lipid